Lataa...
Combining an epithelial repair factor and anti‐fibrotic with a corticosteroid offers optimal treatment for allergic airways disease
BACKGROUND AND PURPOSE: We evaluated the extent to which individual versus combination treatments that specifically target airway epithelial damage [trefoil factor‐2 (TFF2)], airway fibrosis [serelaxin (RLX)] or airway inflammation [dexamethasone (DEX)] reversed the pathogenesis of chronic allergic...
Tallennettuna:
| Julkaisussa: | Br J Pharmacol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4882488/ https://ncbi.nlm.nih.gov/pubmed/27060978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13494 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|